发明名称 |
Ett nytt vaccin som angriper tumörkärl som ett effektivt redskap i tumörterapi |
摘要 |
<p>The invention relates to a composition for the treatment of various cancers. The composition is a vaccine containing sequences of EDB, EDA, annexin A1, endosialin, C domain of tenascin C or magic roundabout (MR) or fragments thereof as single or in a combination coupled to one or several heterologous foreign carrier molecules. The vaccine will produce antibodies that are directed against self proteins which are preferentially expressed in and around tumor vessels. The vaccine is preferably administrated together with an adjuvant.</p> |
申请公布号 |
SE0901565(A1) |
申请公布日期 |
2011.06.16 |
申请号 |
SE20090001565 |
申请日期 |
2009.12.15 |
申请人 |
THERAVAC PHARMACEUTICALS AB |
发明人 |
ANNA-KARIN OLSSON;LARS HELLMAN |
分类号 |
A61K39/385;A61K38/17;A61P35/00 |
主分类号 |
A61K39/385 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|